Showing results (201-210 of 233) with videos related to
Sort By:
Pageof 24
Oncotarget|February 7, 2023
The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility allelesMartin Chevarin, Diana Alcantara, Juliette Albuisson, et al.The Oncologist|March 18, 2015
BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancerNagi S El Saghir, Nathalie K Zgheib, Hussein A Assi, et al.JAMA|June 7, 2011
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndromeValérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, et al.Familial Cancer|November 15, 2011
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trialPascal Pujol, Christine Lasset, Pascaline Berthet, et al.Breast Cancer Research and Treatment|November 14, 2015
Mutation analysis of PALB2 gene in French breast cancer familiesFrancesca Damiola, Inès Schultz, Laure Barjhoux, et al.Human Mutation|December 9, 2021
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type IMolka Sebai, David Tulasne, Sandrine M Caputo, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsSophie M Ginolhac, Sophie Gad, Marilys Corbex, et al.International Journal of Cancer|May 19, 2005
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 geneDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Pathology of ovarian cancers in BRCA1 and BRCA2 carriersSunil R Lakhani, Sanjiv Manek, Frederique Penault-Llorca, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.Pageof 24